Prenatal glucocorticoids exposure and fetal adrenal developmental programming

Area of Science:

• Endocrinology
• Developmental Biology
• Toxicology

Background:

• Synthetic glucocorticoids are clinically used for fetal and maternal conditions.
• Prenatal exposure to glucocorticoids (exogenous or endogenous) can adversely affect fetal development.
• Glucocorticoid levels are critical for fetal maturation and long-term health outcomes.

Purpose of the Study:

• To review recent advances in understanding prenatal glucocorticoid exposure and fetal adrenal developmental programming.
• To elucidate the intrauterine mechanisms underlying glucocorticoid-induced adrenal alterations.
• To highlight the significance for explaining adrenal developmental toxicity and the origins of adult diseases.

Main Methods:

• Literature review of studies on prenatal glucocorticoid exposure and adrenal development.
• Analysis of mechanisms linking prenatal glucocorticoid exposure to adrenal dysplasia and dysfunction.
• Examination of gender differences in fetal adrenal programming.

Main Results:

• Prenatal glucocorticoid exposure is linked to fetal adrenal dysplasia and dysfunction, persisting postnatally and into adulthood.
• Fetal adrenal dysplasia is associated with increased susceptibility to chronic diseases in adulthood.
• Significant gender differences exist in the programming of adrenal development by prenatal glucocorticoids.

Conclusions:

• Prenatal glucocorticoid exposure significantly alters fetal adrenal development, with long-lasting consequences.
• Understanding these programming mechanisms is crucial for addressing adrenal developmental toxicity.
• This research provides insights into the intrauterine origins of adult-onset chronic diseases.